prostate cancer

Chapters Timeline: 4:48 Physical activity and exercise are important to make you feel better plus mental health booster 5:31 What comes to mind from the Genetics lecture? 9:24 How does liquid biopsies relate to early screening? 14:29 15-20 years ago total body CT scans not finding...

0:22 What is the difference between a "genetic" and a "genomic" test? 1:12 How important is genetic or genomic testing to the average prostate cancer patient? 3:31 Do 5% of people have a BRCA mutation? 3:42 Should all prostate cancer patients test to see if they have a BRCA mutation? 5:09...

"We've been doing a lot of work at Johns Hopkins using high-dose testosterone therapies to treat patients with metastatic prostate cancer," says Mark C. Markowski, MD, PhD. https://www.urologytimes.com/view/bipolar-androgen-therapy-in-prostate-cancer-current-evidence-and-next-steps In this...

Background and purpose To determine the rate and time of testosterone (T) recovery in patients (pts) with localised prostate cancer treated with radiotherapy plus 0-, 6-, 18- or 36-month of androgen deprivation therapy (ADT).Materials and methods In 1230 pts with prostate cancer randomised into...

https://pcri.org/2024-midyear-update

Dr. Michael Kipper, MD is one of the nation’s foremost experts in PET/CT imaging technology for the diagnosis of cancer and brain disorders. He is the author of several medical textbooks and numerous professional journal articles on imaging techniques for the evaluation of cancer and other...

10 Years of MRI-Targeted Biopsy: What We Have Learned, and What We Have Yet to Learn by Samir S. Taneja, MD, The James M. Neissa and Janet Riha Neissa Professor of Urologic Oncology, Professor of Urology, Radiology, and Biomedical Engineering, GU Program Leader, Perlmutter Cancer Center...

I was recently honored to be a guest speaker among the innovators, stakeholders, and pioneering minds in managing benign prostate hyperplasia at the annual assembly of the Society of Benign Prostate Disease, held in Dallas this February. Today, I am delighted to have one of the Society of...

Chapters: 2:07 What is the pathology process, and what does a Gleason score mean? 4:54 How should a patient broach questions about treatment with their physician? 9:27 Should patients seek out their pathology report? Can they trust it? 11:22 Can Gleason 6 ever metastasize? 13:04 How likely...

In today's episode with Stacey Loeb, we're delving into the critical topic of prostate cancer — sifting truth from myths and exploring both prevention and treatment options. Dr. Loeb, a professor of urology with a personal investment in the field, joins us to debunk common misinformation about...

Focal Therapy in Prostate Cancer: Is it Ready for Prime Time? By Dr. Sandra Kim, Uro-Oncology Fellow, Department of Urologic Sciences, University of British Columbia

1:02 What is PSA used for, and how is it measured? 2:36 Is PSA the only way to screen for prostate cancer? 4:53 Is there any reason to get a Digital Rectal Exam? 5:47 What is PSA density, and how large is the average prostate? 7:13 How accessible and affordable are MRIs, usually? 7:38 How...

In this comprehensive interview, host Dr. Geo chats with guest expert Dr. Samir Taneja from NYU Langone Medical Center. They unpack the shift in prostate cancer diagnostics from traditional methodologies to more effective approaches using MRI and ultrasound technology. They also touch on the...

Weighing the possible side effects of prostate cancer treatments while considering various treatment options can be a daunting challenge for men and their loved ones. We are excited to partner with BioProtect for this episode, with our distinguished guest, Dr. Jonathan Tward, a Radiation...

1:03 At what stage of prostate cancer would TULSA-PRO be most useful? 3:15 At what Gleason score is TULSA-PRO most often recommended? 4:15 How long does a usual TULSA-PRO procedure usually take to complete? 4:58 What are the most common TULSA-PRO side effects? 5:45 Is urethral scar tissue a...

On October 17, Dr. Abraham Morgentaler, son of writer Chava Rosenfarb, delivered a lecture on "Lodz, testosterone and human dignity" as part of the International Scientific Conference "CHAVA ROSENFARB AND JEWISH WRITERS OF THE 20th CENTURY." In this lecture, Dr. Morgentaler described his...

Chapters 1:08 What are the new PARP Inhibitors, Talzenna and Akegga? 2:18 How effective has PSMA been at helping patients delay chemotherapy? 5:08 What was the state of active surveillance in 2023? 5:56 What is Prostox and can it apply to spot radiation? 7:49 What was the state of Pluvicto...

BACKGROUND Prostate cancer is a prevalent disease that urgently needs to address its treatment-related complications. By examining existing evidence on the association between Androgen Deprivation Therapy (ADT) and dementia, this study contributes to the understanding of potential risks. We...

Dr. Ryan Owen, Urologist at Covenant Health, discusses the important topics of erectile dysfunction and incontinence for prostate cancer patients. He helps you recognize signs and symptoms, as well as explore the array of treatment options available. Whether you're a patient, caregiver, or...

Abstract IMPORTANCE The effect of testosterone replacement therapy (TRT) on the risk of prostate cancer and other adverse prostate events is unknown. OBJECTIVE To compare the effect of TRT vs placebo on the incidences of high-grade prostate cancers (Gleason score 4 + 3), any prostate...

Today, we're joined by Charles Hilson, a patient advocate and penile rehabilitation expert who embarked on a journey to restore his intimate life after prostate cancer surgery. Frustrated by the lack of information, Charles now dedicates himself to educating others about penile health. Charles...

Prostate Cancer treatments cause penises to shorten. Dr. Kohler explains why and what if anything can be done to restore its length. Tobias S. Kohler, M.D., M.P.H., is a urologist, with a specialty in erectile dysfunction. Dr. Kohler is a physician trainer for penile prosthesis surgery in the...

Cancer treatments damage men's ability to enjoy sex. Dr. Kohler talks about ways you and your urologist can restore your sexual functioning and enjoyment. Tobias S. Kohler, M.D., M.P.H., is a urologist, with a specialty in erectile dysfunction. Dr. Kohler is a physician trainer for penile...

E. David Crawford, MD, Editor-in-Chief of Grand Rounds in Urology, sits down to talk about how patients and their loved ones can best navigate a prostate cancer diagnosis with David Mobley, MD, FACS, co-author of the book, “Prostate Cancer: Expert Advice for Helping Your Loved One.

https://www.onclive.com/view/trt-in-patients-with-prostate-cancer-on-active-surveillance-are-we-really-putting-gas-on-fire- Investigators hypothesized that testosterone replacement does not have a negative impact on the oncologic outcomes of treatment-naive patients with prostate cancer on...

https://www.physicianspractice.com/view/the-alamo-redux-or-how-davids-defeat-the-goliaths-of-healthcare David against health care Goliaths In the late 1980s, a urologist, Dr. Abraham Morgentaler, researched the relationship between testosterone and prostate cancer. Since the early 1950s...

We are delighted to partner with Oxford Biodynamics for today’s episode with Dr. Robert Heaton, who joins us to discuss a ground-breaking new prostate cancer screening test that predicts the risk of prostate cancer with 94% accuracy, using a simple blood test. Dr. Heaton is a board-certified...

The video presented a treatment called Bipolar Androgen Therapy (BAT) for prostate cancer, in which patients are given high doses of testosterone to resensitize the cancer to hormone therapy. Dr. Sam Denme discussed the concept, results from trials, and future research, highlighting the...

Mohit Khera, MD, MBA, MPH, discusses the role of testosterone in the diagnosis and treatment of prostate cancer.